Atea Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $151k | 45k | 3.35 |
| 2024-06-30 | $150k | 45k | 3.31 |
| 2023-12-31 | $144k | 47k | 3.05 |
| 2023-09-30 | $142k | 47k | 3.00 |
| 2023-06-30 | $177k | 47k | 3.74 |
| 2023-03-31 | $158k | 47k | 3.35 |
| 2022-12-31 | $227k | 47k | 4.81 |
| 2022-09-30 | $269k | 47k | 5.70 |
| 2022-06-30 | $277k | 39k | 7.09 |
| 2022-03-31 | $282k | 39k | 7.22 |
| 2021-12-31 | $220k | 25k | 8.94 |
| 2021-09-30 | $864k | 25k | 35.06 |
| 2021-06-30 | $529k | 25k | 21.48 |
| 2021-03-31 | $343k | 5.5k | 61.75 |
| 2020-12-31 | $290k | 6.9k | 41.81 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors